Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 5,400
- Avg volume
- 34,584
- Day's range
- $0.01 – $0.01
- Shares out
- —
- Stochastic %K
- 2%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware an...
Show more
Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware and reconstruction software products. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; and imaging chains and custom X-ray imaging solutions, as well as engineering contract services and spare parts. The company has a strategic partnership with Billion Prima to develop and commercialize a baggage and parcel scanner product. Micro-X Limited was incorporated in 2011 and is based in Adelaide, Australia.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 61 8 7099 3966
- Website
- https://www.micro-x.com
- Address
- A14, 6 MAB Eastern Promenade, 1284 South Road Tonsley, Adelaide, Australia
Latest news
No headlines yet.